Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Butyrylcholinesterase (BChE) deficiency is a metabolic disorder characterized by prolonged apnoea after the use of certain anesthetic drugs, including the muscle relaxants succinylcholine or mivacurium and other ester local anesthetics. The duration of the prolonged apnoea varies significantly depending on the extent of the enzyme deficiency.
Data assembled from 7 of 12 sources · Last updated Sep 19, 2026, 4:31 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Features include very common findings: Abnormal circulating enzyme concentration or activity; and common findings: Respiratory failure. 10 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Lungs and breathing | 3 | Apnea, Respiratory failure, Respiratory failure requiring assisted ventilation |
Heart and blood vessels | 2 | Congestive heart failure, Myocardial infarction |
Digestive system | 1 | Abnormality of the liver |
Neoplasm | 1 | Neoplasm |
BCHE encodes butyrylcholinesterase (602 aa). Esterase with broad substrate specificity. Contributes to the inactivation of the neurotransmitter acetylcholine. Can degrade neurotoxic organophosphate esters Highest expression in Fallopian Tube (40.6 TPM) and Esophagus Muscularis (36.7 TPM).
Butyrylcholinesterase deficiency is associated with mutations in the BCHE gene on chromosome 3.
BCHE is classified as a druggable target (Druggable Genome and Enzyme categories) with score 3.9.
Genetic testing for BCHE is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for butyrylcholinesterase deficiency has been reported in the published literature.
Phenotype severity distribution: 1 very common feature, 1 common feature.
Estimated prevalence: 1-9 in 100,000 (Uncommon).
1 clinical trial registered. Interventions under study include drug therapy. Pipeline includes 1 NA. Research is primarily sponsored by academic and government institutions.
13 publications have been identified in PubMed for butyrylcholinesterase deficiency. Research spans Case Report / Case Series (46%), Review / Meta-Analysis (38%), and Diagnostic / Biomarker (8%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 6 | 46% |
Research summaries | 5 | 38% |
Testing and diagnosis research | 1 | 8% |
Laboratory research | 1 | 8% |
Snak de Souza CD (2026). [PMID: 42120224](https://pubmed.ncbi.nlm.nih.gov/42120224/). *Br J Anaesth*. [Review / Meta-Analysis]
Trujillo R (2026). [PMID: 31082076](https://pubmed.ncbi.nlm.nih.gov/31082076/). *Unknown Journal*. [Review / Meta-Analysis]
Schulze-Berge J (2025). [PMID: 40148900](https://pubmed.ncbi.nlm.nih.gov/40148900/). *J Med Case Rep*. [Case Report / Case Series]
Tyler J (2025). [PMID: 40257830](https://pubmed.ncbi.nlm.nih.gov/40257830/). *J Am Acad Orthop Surg Glob Res Rev*. [Case Report / Case Series]
Dingová D (2025). [PMID: 39836467](https://pubmed.ncbi.nlm.nih.gov/39836467/). *Am J Physiol Heart Circ Physiol*. [Basic Science / Preclinical]
Nguyen JQ (2025). [PMID: 40778538](https://pubmed.ncbi.nlm.nih.gov/40778538/). *Pharmacotherapy*. [Review / Meta-Analysis]
Celis V (2025). [PMID: 39331762](https://pubmed.ncbi.nlm.nih.gov/39331762/). *Neurodiagn J*. [Case Report / Case Series]
Ho E (2025). [PMID: 40985564](https://pubmed.ncbi.nlm.nih.gov/40985564/). *A A Pract*. [Case Report / Case Series]
Uzun DD (2025). [PMID: 40790181](https://pubmed.ncbi.nlm.nih.gov/40790181/). *BMC Pediatr*. [Case Report / Case Series]
Tokunaga N (2025). [PMID: 39814397](https://pubmed.ncbi.nlm.nih.gov/39814397/). *Tohoku J Exp Med*. [Diagnostic / Biomarker]